Sign in

CIK 0001593899

  • Non-accelerated filer
  • Smaller reporting company

Atea Pharmaceuticals, Inc.

Sign in to watch
Ticker
AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
460574869
Phone
+1 857-284-8891
Business address
225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-31 Vavricka John Chief Commercial Officer Exercise or conversion +42,083 94,164
2026-01-31 Vavricka John Chief Commercial Officer Shares withheld for taxes −11,570 $4.24 $49K 82,594
2026-01-31 Vavricka John Chief Commercial Officer Exercise or conversion · Restricted Stock Units −33,333 0
2026-01-31 Vavricka John Chief Commercial Officer Exercise or conversion · Restricted Stock Units −8,750 0
2026-01-31 Vavricka John Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +119,520 119,520
2025-01-31 Vavricka John Chief Commercial Officer Exercise or conversion +33,333 54,848
2025-01-31 Vavricka John Chief Commercial Officer Grant or award +8,750 63,598
2025-01-31 Vavricka John Chief Commercial Officer Shares withheld for taxes −11,517 $3.06 $35K 52,081
2025-01-31 Vavricka John Chief Commercial Officer Exercise or conversion · Restricted Stock Units −33,333 33,333
2025-01-31 Vavricka John Chief Commercial Officer Grant or award · Restricted Stock Units +8,750 8,750
2025-01-31 Vavricka John Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +132,800 132,800
2024-02-01 Vavricka John Chief Commercial Officer Sale −11,819 $3.84 $45K 21,515
2024-01-31 Vavricka John Chief Commercial Officer Exercise or conversion +33,334 33,334
2024-01-31 Vavricka John Chief Commercial Officer Exercise or conversion · Restricted Stock Units −33,334 66,666
2024-01-31 Vavricka John Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +132,800 132,800
2023-01-31 Vavricka John Chief Commercial Officer Grant or award · Restricted Stock Units +100,000 100,000
2023-01-31 Vavricka John Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +140,000 140,000
2022-01-31 Vavricka John Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +135,000 135,000
2021-01-29 Vavricka John Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +117,300 117,300
2020-11-03 Vavricka John Chief Commercial Officer Conversion +82,508 82,508

Page 1 of 2 · 21 trades